Medication info
Il Yang Losartan Tablets 100 mg (Losartan Potassium)

Il Yang Losartan Tablets 100 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
Il Yang Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 200803248 · Notified 2008.03.24 · Insurance code 641702880

Summary

Main use
Treatment of kidney disease in patients with hypertension or type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium taken orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the response is inadequate, the same total daily dose may be divided and taken orally twice daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Renal disease in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations No initial dose adjustment is required in patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is required. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg once daily is recommended. For patients who may have reduced effective circulating blood volume (e.g., patients receiving diuretics), an initial dose of 25 mg once daily is recommended (see Precautions). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years and older weighing 20 kg or more but less than 50 kg who can swallow tablets: The recommended dose is 25 mg once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older weighing 50 kg or more: The usual recommended dose is 50 mg once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for children under 6 years of age, children with a glomerular filtration rate below 30 mL/min/1.73㎡, or children with hepatic impairment.

Ingredients

Manufacturer
Il Yang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of kidney disease in patients with hypertension or type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used for the treatment of hypertension. It is particularly effective in preventing and treating kidney disease in patients with type 2 diabetes. It helps stabilize blood pressure and protect kidney function, contributing to overall health improvement. Therefore, this medication is used to alleviate kidney complications associated with hypertension.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium taken orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the response is inadequate, the same total daily dose may be divided and taken orally twice daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Renal disease in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations No initial dose adjustment is required in patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is required. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg once daily is recommended. For patients who may have reduced effective circulating blood volume (e.g., patients receiving diuretics), an initial dose of 25 mg once daily is recommended (see Precautions). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years and older weighing 20 kg or more but less than 50 kg who can swallow tablets: The recommended dose is 25 mg once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older weighing 50 kg or more: The usual recommended dose is 50 mg once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for children under 6 years of age, children with a glomerular filtration rate below 30 mL/min/1.73㎡, or children with hepatic impairment.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters. Therefore, women who are pregnant or may become pregnant should not take it. If a pregnant woman takes this medication, fetal lung development impairment, skeletal malformations, and kidney dysfunction may occur, necessitating an immediate cessation of use upon confirmation of pregnancy. It should not be administered to patients with certain conditions, such as those allergic to this medication or its components, severe liver impairment, or hereditary angioedema. Caution should also be exercised in patients with severely reduced kidney function or primary aldosteronism. Elderly patients, those with hyperkalemia, and individuals with mild to moderate liver impairment should use this medication more cautiously, as excessive blood pressure reduction may lead to cardiac or cerebral issues. Generally, this medication is well tolerated, but side effects such as dizziness, muscle cramps, back pain, and upper respiratory infections may occur. Rarely, serious side effects such as angioedema, liver function impairment, myalgia, hyperkalemia, hypotension, and renal failure can occur, and medical consultation should be sought immediately if any unusual symptoms arise. This medication may interact with other drugs, especially potassium-sparing diuretics, potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), and lithium, requiring caution when taken together. Regular monitoring of blood pressure, kidney function, and serum potassium levels is necessary during use. Pregnant and breastfeeding women should avoid taking this medication, and if unavoidable, breastfeeding should be discontinued. This medication should not be used in children, especially those under 6 years old or with severely reduced kidney function. In cases of overdose, hypotension and bradycardia may occur, necessitating immediate medical attention. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur, and it should be stored out of reach of children.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 127 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm skin peeling
  • hemolytic phenomenon
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • neuroexcitability
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reactions
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation and pain in eyes
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturnal enuresis
  • frequent urination
  • urinary tract infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • fatigue
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular extrasystoles
  • atrial fibrillation
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is important to maintain a room temperature between 1 and 30 degrees Celsius to preserve its efficacy.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.